4.8
97.9 %
96.1 %
Indicators in the Citation impact, Journal impact and Co‑publishing tabs are based on Web of Science publications only. Corresponding Scopus indicators can be found under the Scopus tab.
Overall Web of Science coverage for peer reviewed publications in this unit is good, 97.9%.
Note that the coverage numbers for Web of Science and Scopus apply to publications in the KTH bibliometric database Bibmet. If a WoS-id or Scoupus-id from DiVA can not be matched in Bibmet, it does not count as covered.
The bibliometric indicators referred are based on publications registered in DiVA. Only publications from currently employed researchers at KTH are included. The rolling nature of this report means that it provides more of a current overview and less of a historic stable trend, since it excludes publications written by researchers that are no longer affiliated to KTH, but have been at some point in time.
Indicators in the Citation impact, Journal impact and Co‑publishing tabs are based on Web of Science publications only. Corresponding Scopus indicators can be found under the Scopus tab.
Publication data is available only after login.
| DiVA publication type | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | Publications | WoS coverage | Scopus coverage |
|---|---|---|---|---|---|---|---|---|---|---|
| Article, peer review | 2.4 | 1.3 | 5.9 | 3.2 | 2.4 | 4.0 | 2.5 | 21.7 | 97.9% | 1 |
| Article, other | 0.3 | 0.8 | 1.1 | 1.2 | 2.9 | 0.7 | 0.3 | 7.4 | 100.0% | 0 |
| Chapter in book | NA | NA | NA | 2.3 | 1.4 | 0.8 | NA | 4.5 | 0.0% | 1 |
| Doctoral thesis | NA | 2.0 | NA | NA | NA | NA | 2.0 | 4.0 | 0.0% | 0 |
| DiVA publication type | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | Publications | WoS coverage | Scopus coverage |
|---|---|---|---|---|---|---|---|---|---|---|
| Article, peer review | 14 | 9 | 19 | 18 | 13 | 26 | 22 | 121 | 97.5% | 1 |
| Article, other | 2 | 4 | 6 | 4 | 10 | 6 | 3 | 35 | 100.0% | 0 |
| Chapter in book | NA | NA | NA | 4 | 2 | 1 | NA | 7 | 0.0% | 1 |
| Doctoral thesis | NA | 2 | NA | NA | NA | NA | 2 | 4 | 0.0% | 0 |
| Publication Year | Publications | Total Citations | Average Citations | Uncited publications | Share uncited |
|---|---|---|---|---|---|
| 2014 | 2.0 | 14.9 | 7.3 | 0.0 | 0.0% |
| 2015 | 1.2 | 68.9 | 59.8 | 0.2 | 19.3% |
| 2016 | 5.9 | 24.6 | 4.2 | 0.6 | 10.5% |
| 2017 | 2.8 | 58.8 | 21.2 | 0.0 | 0.0% |
| 2018 | 2.3 | 17.9 | 7.7 | 0.0 | 0.0% |
| Total | 14.2 | 185.0 | 13.0 | 0.8 | 5.9% |
| Publication years | Publications | Average Cf | Top 10% publications | Share Top 10% |
|---|---|---|---|---|
| 2014-2016 | 9.1 | 2.40 | 0.6 | 6.6% |
| 2015-2017 | 9.7 | 2.65 | 0.8 | 8.5% |
| 2016-2018 | 10.9 | 1.34 | 0.9 | 7.9% |
| 2017-2019 | 8.7 | 1.75 | 1.4 | 16.2% |
| Total | 17.8 | 2.08 | 2.0 | 11.2% |
This table is based on Web of Science publication types Article, Proceedings paper, Review, Letter and Editorial.
Rows are based on at least 9 (full counted) publications with good Web of Science coverage (at least 84.8%).
(DiVA publication types Article, peer review and Conference paper, peer review)
Indicators based on < 50 publications are considered unreliable
This table is based on Web of Science publication types Article and Review.
Rows are based on at least 40 (full counted) publications with good Web of Science coverage (at least 96.2%).
(DiVA publication type Article, peer review)
Indicators based on < 50 publications are considered unreliable
| Publication years | Publications | Average Journal Cf | Publications in Top 20% journals | Share Top 20% journals |
|---|---|---|---|---|
| 2014-2016 | 8.8 | 0.92 | 1.0 | 11.3% |
| 2015-2017 | 9.7 | 1.01 | 1.6 | 16.2% |
| 2016-2018 | 10.9 | 0.92 | 1.4 | 12.8% |
| 2017-2019 | 8.6 | 1.16 | 2.0 | 23.3% |
| 2018-2020 | 8.4 | 1.26 | 2.7 | 32.1% |
| Total | 19.9 | 1.13 | 4.6 | 23.2% |
This table is based on Web of Science publication types Article and Review.
Rows are based on at least 40 (full counted) publications with good Web of Science coverage (at least 96.2%).
(DiVA publication type Article, peer review)
Indicators based on < 50 publications are considered unreliable
| Publication years | Publications | Swedish non-university co-publications | Share Swedish non-university | International co-publications | Share international |
|---|---|---|---|---|---|
| 2014-2016 | 38 | 12 | 31.6% | 21 | 55.3% |
| 2015-2017 | 42 | 20 | 47.6% | 23 | 54.8% |
| 2016-2018 | 47 | 21 | 44.7% | 27 | 57.4% |
| 2017-2019 | 53 | 29 | 54.7% | 37 | 69.8% |
| 2018-2020 | 59 | 34 | 57.6% | 45 | 76.3% |
| Total | 113 | 55 | 48.7% | 76 | 67.3% |
This table is based on Web of Science publication types Article and Review.
Rows are based on at least 38 (full counted) publications with good Web of Science coverage (at least 95.2%).
(DiVA publication type Article, peer review)
Indicators based on < 50 publications are considered unreliable
| Country | Publications | 1-10 auth | 11-50 auth | 51-200 auth | Over 200 auth | Publications (frac) |
|---|---|---|---|---|---|---|
| United States | 30 | 8 | 17 | 3 | 2 | 3.6 |
| United Kingdom | 30 | 7 | 19 | 2 | 2 | 3.4 |
| Spain | 22 | 8 | 12 | 0 | 2 | 2.8 |
| Netherlands | 20 | 6 | 10 | 2 | 2 | 2.4 |
| Denmark | 21 | 1 | 15 | 3 | 2 | 2.0 |
| Germany | 24 | 4 | 16 | 2 | 2 | 1.9 |
| France | 13 | 1 | 9 | 1 | 2 | 1.4 |
| Norway | 7 | 1 | 4 | 0 | 2 | 1.2 |
| China | 6 | 2 | 4 | 0 | 0 | 1.0 |
| Korea, Republic of | 6 | 3 | 3 | 0 | 0 | 1.0 |
| Finland | 10 | 0 | 8 | 2 | 0 | 0.9 |
| Poland | 5 | 1 | 2 | 0 | 2 | 0.7 |
| Canada | 6 | 2 | 4 | 0 | 0 | 0.7 |
| Switzerland | 12 | 1 | 7 | 2 | 2 | 0.6 |
| Singapore | 10 | 1 | 7 | 2 | 0 | 0.6 |
| Italy | 10 | 1 | 5 | 2 | 2 | 0.5 |
| Australia | 5 | 2 | 3 | 0 | 0 | 0.5 |
| Austria | 7 | 1 | 4 | 2 | 0 | 0.4 |
| Kenya | 2 | 1 | 1 | 0 | 0 | 0.3 |
| Belgium | 3 | 1 | 0 | 0 | 2 | 0.3 |
| Czech Republic | 1 | 1 | 0 | 0 | 0 | 0.2 |
| New Zealand | 1 | 0 | 1 | 0 | 0 | 0.2 |
| Uganda | 2 | 0 | 2 | 0 | 0 | 0.2 |
| Colombia | 1 | 1 | 0 | 0 | 0 | 0.2 |
| Israel | 2 | 0 | 2 | 0 | 0 | 0.2 |
| Iceland | 2 | 0 | 2 | 0 | 0 | 0.2 |
| Ireland | 2 | 0 | 2 | 0 | 0 | 0.2 |
| Brazil | 1 | 1 | 0 | 0 | 0 | 0.1 |
| India | 2 | 0 | 2 | 0 | 0 | 0.1 |
| Malaysia | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Thailand | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Iran, Islamic Republic of | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Japan | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Nigeria | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Hungary | 3 | 0 | 1 | 0 | 2 | 0.1 |
| Ethiopia | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Lithuania | 1 | 0 | 0 | 0 | 1 | 0.0 |
| Organization | Organization type | Country | Publications | 1-10 auth | 11-50 auth | 51-200 auth | Over 200 auth | Publications (frac) |
|---|---|---|---|---|---|---|---|---|
| Karolinska Institutet | University | Sweden | 86 | 29 | 54 | 1 | 2 | 14.1 |
| Uppsala University | University | Sweden | 45 | 8 | 34 | 1 | 2 | 6.7 |
| Karolinska University Hospital | University Hospital | Sweden | 38 | 9 | 27 | 0 | 2 | 5.9 |
| CHUAC | University Hospital | Spain | 9 | 7 | 2 | 0 | 0 | 1.8 |
| University of Gothenburg | University | Sweden | 11 | 1 | 9 | 1 | 0 | 1.7 |
| Sahlgrenska University Hospital | University Hospital | Sweden | 10 | 1 | 8 | 1 | 0 | 1.6 |
| Technical University of Denmark (DTU) | University | Denmark | 15 | 0 | 12 | 3 | 0 | 1.5 |
| Stanford University | University | United States | 7 | 2 | 4 | 1 | 0 | 1.4 |
| University of Oxford | University | United Kingdom | 13 | 5 | 6 | 2 | 0 | 1.4 |
| Stockholm University | University | Sweden | 8 | 1 | 7 | 0 | 0 | 1.2 |
| Institute of Biomedical Research of A Coruña (inibic) | Institute | Spain | 6 | 5 | 1 | 0 | 0 | 1.1 |
| University College London | University | United Kingdom | 5 | 0 | 5 | 0 | 0 | 1.0 |
| Lund University | University | Sweden | 10 | 2 | 6 | 2 | 0 | 1.0 |
| Umeå University | University | Sweden | 13 | 2 | 8 | 1 | 2 | 1.0 |
| Gävleborg County Council | Other health services | Sweden | 3 | 3 | 0 | 0 | 0 | 0.9 |
| Leiden University | University | Netherlands | 8 | 2 | 3 | 2 | 1 | 0.9 |
| Stockholms läns landsting | Other health services | Sweden | 7 | 2 | 5 | 0 | 0 | 0.8 |
| University of Helsinki | University | Finland | 3 | 0 | 3 | 0 | 0 | 0.7 |
| Atlas Antibodies AB | Company | Sweden | 3 | 0 | 3 | 0 | 0 | 0.6 |
| Sci Life Lab | University Other | Sweden | 8 | 2 | 4 | 0 | 2 | 0.6 |
| University of Copenhagen | University | Denmark | 13 | 1 | 8 | 2 | 2 | 0.6 |
| Skåne University Hospital | University Hospital | Sweden | 7 | 1 | 5 | 0 | 1 | 0.6 |
| University of Tromsø | University | Norway | 2 | 0 | 2 | 0 | 0 | 0.6 |
| National University of Singapore | University | Singapore | 9 | 1 | 6 | 2 | 0 | 0.5 |
| Inserm | Institute | France | 5 | 0 | 4 | 1 | 0 | 0.5 |
| Shanghai Jiao Tong University | University | China | 1 | 1 | 0 | 0 | 0 | 0.5 |
| University of Geneva | University | Switzerland | 9 | 0 | 7 | 2 | 0 | 0.5 |
| University of Salamanca | University | Spain | 2 | 2 | 0 | 0 | 0 | 0.5 |
| St Antonius Hosp | Other health services | Netherlands | 2 | 1 | 1 | 0 | 0 | 0.4 |
| Swedish FTD Initiat | NA | Sweden | 1 | 0 | 1 | 0 | 0 | 0.4 |
| AstraZeneca | Company | Sweden | 6 | 0 | 4 | 0 | 2 | 0.4 |
| Rockefeller University | University | United States | 2 | 1 | 1 | 0 | 0 | 0.4 |
| Institute for Systems Biology | Institute | United States | 4 | 2 | 2 | 0 | 0 | 0.4 |
| Macquarie University | University | Australia | 4 | 2 | 2 | 0 | 0 | 0.4 |
| University of Michigan | University | United States | 4 | 2 | 2 | 0 | 0 | 0.4 |
| Inha University | University | Korea, Republic of | 1 | 1 | 0 | 0 | 0 | 0.4 |
| Carlos III Health Institute | Institute | Spain | 2 | 1 | 1 | 0 | 0 | 0.4 |
| Imperial College London | University | United Kingdom | 9 | 0 | 6 | 1 | 2 | 0.4 |
| Hôpital Bichat-Claude Bernard | University Hospital | France | 1 | 1 | 0 | 0 | 0 | 0.3 |
| Life Technologies | Company | Norway | 1 | 1 | 0 | 0 | 0 | 0.3 |
| St Antonius Hosp Pulmonol | Other health services | Netherlands | 1 | 1 | 0 | 0 | 0 | 0.3 |
| Norrland’s University Hospital | University Hospital | Sweden | 2 | 1 | 1 | 0 | 0 | 0.3 |
| University of Cambridge | University | United Kingdom | 5 | 1 | 3 | 1 | 0 | 0.3 |
| VU University Amsterdam | University | Netherlands | 4 | 0 | 3 | 0 | 1 | 0.3 |
| University Hospital North Norway | University Hospital | Norway | 1 | 0 | 1 | 0 | 0 | 0.3 |
| Linköping University | University | Sweden | 3 | 0 | 3 | 0 | 0 | 0.3 |
| Affin Prote | NA | Sweden | 1 | 1 | 0 | 0 | 0 | 0.3 |
| Mercene Labs AB | Company | Sweden | 1 | 1 | 0 | 0 | 0 | 0.3 |
| Vita-Salute San Raffaele University (UniSR) | University | Italy | 1 | 1 | 0 | 0 | 0 | 0.3 |
| University of British Columbia | University | Canada | 3 | 1 | 2 | 0 | 0 | 0.3 |
| RIER RED Inflamac & Enfermedades Reumat | NA | Spain | 3 | 1 | 2 | 0 | 0 | 0.3 |
| Aix-Marseille University | University | France | 4 | 0 | 3 | 0 | 1 | 0.3 |
| Institute of Cardiometabolism and nutrition (ICAN) | Institute | France | 3 | 0 | 3 | 0 | 0 | 0.3 |
| Cedars-Sinai | Other health services | United States | 3 | 1 | 2 | 0 | 0 | 0.3 |
| Medical University of Warsaw | University | Poland | 1 | 0 | 1 | 0 | 0 | 0.3 |
| Copenhagen University Hospitals | University Hospital | Denmark | 5 | 0 | 3 | 2 | 0 | 0.3 |
| Seoul National University | University | Korea, Republic of | 2 | 1 | 1 | 0 | 0 | 0.3 |
| European Sleep and Research Society (ESRS) | Other health services | Finland | 1 | 0 | 1 | 0 | 0 | 0.3 |
| University of Manitoba | University | Canada | 2 | 1 | 1 | 0 | 0 | 0.3 |
| University of Nairobi | University | Kenya | 2 | 1 | 1 | 0 | 0 | 0.3 |
| University of Washington | University | United States | 2 | 1 | 1 | 0 | 0 | 0.3 |
| University of Southampton | University | United Kingdom | 5 | 0 | 3 | 0 | 2 | 0.3 |
| Chalmers University of Technology | University | Sweden | 4 | 0 | 3 | 1 | 0 | 0.3 |
| German Research Center for Environmental Health - Helmholtz Zentrum München | Institute | Germany | 7 | 0 | 5 | 2 | 0 | 0.3 |
| German Cancer Research Center | Institute | Germany | 3 | 0 | 3 | 0 | 0 | 0.3 |
| Swedish University of Agricultural Sciences | University | Sweden | 3 | 0 | 3 | 0 | 0 | 0.3 |
| Harvard University | University | United States | 6 | 0 | 4 | 2 | 0 | 0.3 |
| Hasselt University | University | Belgium | 1 | 1 | 0 | 0 | 0 | 0.2 |
| Inibic C Hosp Univ A Coruna | NA | Spain | 1 | 1 | 0 | 0 | 0 | 0.2 |
| Northeastern University | University | China | 1 | 1 | 0 | 0 | 0 | 0.2 |
| Palacky University | University | Czech Republic | 1 | 1 | 0 | 0 | 0 | 0.2 |
| University of Warsaw | University | Poland | 1 | 1 | 0 | 0 | 0 | 0.2 |
| Technical University of Munich | University | Germany | 6 | 0 | 4 | 2 | 0 | 0.2 |
| King’s College London | University | United Kingdom | 3 | 0 | 3 | 0 | 0 | 0.2 |
| Newcastle University | University | United Kingdom | 7 | 0 | 5 | 2 | 0 | 0.2 |
| Hosp Clin Univ Santiago | NA | Spain | 3 | 0 | 3 | 0 | 0 | 0.2 |
| University of Exeter | University | United Kingdom | 7 | 0 | 5 | 2 | 0 | 0.2 |
| Bordeaux University Hospital (CHU) | University Hospital | France | 1 | 0 | 1 | 0 | 0 | 0.2 |
| CHU Besancon | NA | France | 1 | 0 | 1 | 0 | 0 | 0.2 |
| Ctr Expert Parkinson Toulouse | NA | France | 1 | 0 | 1 | 0 | 0 | 0.2 |
| Erasmus University Rotterdam | University | Netherlands | 1 | 1 | 0 | 0 | 0 | 0.2 |
| Friedrich-Alexander-Universität Erlangen-Nürnberg | University | Germany | 1 | 1 | 0 | 0 | 0 | 0.2 |
| German Center for Neurodegenerative Diseases (DZNE) | Institute | Germany | 1 | 0 | 1 | 0 | 0 | 0.2 |
| New Zealand Brain Res Inst | Institute | New Zealand | 1 | 0 | 1 | 0 | 0 | 0.2 |
| Paul Sabatier University | University | France | 1 | 0 | 1 | 0 | 0 | 0.2 |
| Södersjukhuset | Other health services | Sweden | 1 | 1 | 0 | 0 | 0 | 0.2 |
| University of Bonn | University | Germany | 1 | 0 | 1 | 0 | 0 | 0.2 |
| University of Bordeaux | University | France | 1 | 0 | 1 | 0 | 0 | 0.2 |
| University of Otago | University | New Zealand | 1 | 0 | 1 | 0 | 0 | 0.2 |
| Southern Medical University | University | China | 3 | 0 | 3 | 0 | 0 | 0.2 |
| Medical University of Vienna | University | Austria | 1 | 1 | 0 | 0 | 0 | 0.2 |
| Struct Genom Consortium | NA | Sweden | 1 | 1 | 0 | 0 | 0 | 0.2 |
| University of Cartagena | University | Colombia | 1 | 1 | 0 | 0 | 0 | 0.2 |
| University of Groningen | University | Netherlands | 1 | 1 | 0 | 0 | 0 | 0.2 |
| University of Lille | University | France | 2 | 0 | 2 | 0 | 0 | 0.2 |
| Akershus University Hospital | University Hospital | Norway | 1 | 0 | 1 | 0 | 0 | 0.2 |
| ClinTec | Company | Sweden | 1 | 0 | 1 | 0 | 0 | 0.2 |
| University of Mississippi | University | United States | 1 | 0 | 1 | 0 | 0 | 0.2 |
| Biodonostia Health Research Institute (HRI) | Institute | Spain | 1 | 0 | 1 | 0 | 0 | 0.2 |
| the Basque foundation for science (Ikerbasque) | Other Public | Spain | 1 | 0 | 1 | 0 | 0 | 0.2 |
| University Pierre and Marie Curie | University | France | 2 | 0 | 2 | 0 | 0 | 0.2 |
| Örebro University | University | Sweden | 1 | 0 | 1 | 0 | 0 | 0.2 |
| Spanish National Research Council (CSIC) | Institute | Spain | 2 | 0 | 2 | 0 | 0 | 0.2 |
| Yonsei University | University | Korea, Republic of | 2 | 0 | 2 | 0 | 0 | 0.2 |
| University of A Coruña | University | Spain | 2 | 1 | 1 | 0 | 0 | 0.2 |
| Advice Företagsassistans i Stockholm AB | Company | Sweden | 1 | 0 | 1 | 0 | 0 | 0.2 |
| CIC | Institute | Spain | 1 | 0 | 1 | 0 | 0 | 0.2 |
| Ctr Hosp Reg Univ Lille 2 | NA | France | 1 | 0 | 1 | 0 | 0 | 0.2 |
| Makerere University | University | Uganda | 1 | 0 | 1 | 0 | 0 | 0.2 |
| University College Dublin | University | Ireland | 2 | 0 | 2 | 0 | 0 | 0.2 |
| University of Amsterdam | University | Netherlands | 4 | 0 | 2 | 0 | 2 | 0.2 |
| Hospital de Sant Pau | Other health services | Spain | 2 | 0 | 2 | 0 | 0 | 0.2 |
| La Timone teaching hospital | University Hospital | France | 2 | 0 | 2 | 0 | 0 | 0.2 |
| University Medical Center Hamburg-Eppendorf | University Hospital | Germany | 2 | 0 | 2 | 0 | 0 | 0.2 |
| Kenya Medical Research Institute (KEMRI) | Other Public | Kenya | 1 | 0 | 1 | 0 | 0 | 0.2 |
| Public Health Agency of Canada | Other Public | Canada | 1 | 0 | 1 | 0 | 0 | 0.2 |
| National Research Council (CNR) | Other Public | Italy | 6 | 0 | 4 | 2 | 0 | 0.2 |
| Sanofi | Company | Germany | 6 | 0 | 4 | 2 | 0 | 0.2 |
| University of Dundee | University | United Kingdom | 6 | 0 | 4 | 2 | 0 | 0.2 |
| University of Eastern Finland | University | Finland | 6 | 0 | 4 | 2 | 0 | 0.2 |
| University of Westminster | University | United Kingdom | 4 | 0 | 3 | 1 | 0 | 0.2 |
| Silesian University of Technology | University | Poland | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Univ Caen Normandy | NA | France | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Yale University | University | United States | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Kuopio University Hospital | University Hospital | Finland | 5 | 0 | 4 | 1 | 0 | 0.1 |
| University of Bergen | University | Norway | 3 | 0 | 1 | 0 | 2 | 0.1 |
| Codon Consulting | NA | Sweden | 2 | 0 | 2 | 0 | 0 | 0.1 |
| SIB Swiss Institute of Bioinformatics | Institute | Switzerland | 5 | 0 | 3 | 2 | 0 | 0.1 |
| University of Southern Denmark | University | Denmark | 5 | 0 | 3 | 2 | 0 | 0.1 |
| Amsterdam Rheumatology and Immunology Center (ARC) | Institute | Netherlands | 1 | 1 | 0 | 0 | 0 | 0.1 |
| EUROIMMUN AG | Company | Germany | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Freenome Holdings, Inc. | Company | United States | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Haukeland University Hospital | University Hospital | Norway | 1 | 0 | 1 | 0 | 0 | 0.1 |
| INIBIC Hosp Univ Rio A Coruna | NA | Spain | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Korea Basic Science Institute (KBSI) | Other Public | Korea, Republic of | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Leibniz Institute for Analytical Sciences (ISAS) | Institute | Germany | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Massachusetts Institute of Technology | University | United States | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Max Planck Society for the Advancement of Science (MPG) | Institute | Germany | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Murdoch Children’s Research Institute (MCRI) | Institute | Australia | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Ruhr University Bochum | University | Germany | 1 | 1 | 0 | 0 | 0 | 0.1 |
| State University of Campinas | University | Brazil | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Universidade de São Paulo | University | Brazil | 1 | 1 | 0 | 0 | 0 | 0.1 |
| University of California, San Francisco | University | United States | 1 | 1 | 0 | 0 | 0 | 0.1 |
| University of Melbourne | University | Australia | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Eli Lilly & Co | Company | Austria | 5 | 0 | 4 | 1 | 0 | 0.1 |
| UCB S.A. | Company | United Kingdom | 3 | 1 | 0 | 0 | 2 | 0.1 |
| Ludwig Maximilian University of Munich | University | Germany | 2 | 1 | 0 | 1 | 0 | 0.1 |
| Hop Enfants La Timone | NA | France | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Lab Surgpath | Other health services | India | 2 | 0 | 2 | 0 | 0 | 0.1 |
| University of Zurich | University | Switzerland | 2 | 1 | 0 | 0 | 1 | 0.1 |
| CIFAR | NA | Canada | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Columbia University | University | United States | 1 | 0 | 1 | 0 | 0 | 0.1 |
| ETH Zurich | University | Switzerland | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Harvard T.H. Chan School of Public Health (Harvard School of Public Health) | University | United States | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Mahidol University | University | Thailand | 1 | 1 | 0 | 0 | 0 | 0.1 |
| National University of Malaysia (UKM) | University | Malaysia | 1 | 1 | 0 | 0 | 0 | 0.1 |
| University of Minnesota | University | United States | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Weizmann Institute of Science | University | Israel | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Complement Res Grp | NA | Spain | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Hosp San Pedro Alcantara | NA | Spain | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Hosp Univ Son Espases | NA | Spain | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Kyushu University | University | Japan | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Natl Def Med Coll | NA | Japan | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Region Skåne | Other health services | Sweden | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Royal Melbourne Hospital (RMH) | Other health services | Australia | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Tehran University of Medical Sciences | University | Iran, Islamic Republic of | 1 | 0 | 1 | 0 | 0 | 0.1 |
| UNIV HOSP 12 OCTUBRE | University Hospital | Spain | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Universidad Autónoma de Barcelona | University | Spain | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Universidad Autónoma de Madrid | University | Spain | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Walter and Eliza Hall Institute of Medical Research | Institute | Australia | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Hôpital Européen Georges-Pompidou | Other health services | France | 1 | 0 | 1 | 0 | 0 | 0.1 |
| National Institute for Medical Research (NIMR) | Institute | United Kingdom | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Paris Descartes University | University | France | 1 | 0 | 1 | 0 | 0 | 0.1 |
| University College Hospital, Ibadan | University Hospital | Nigeria | 1 | 0 | 1 | 0 | 0 | 0.1 |
| University of Colorado Denver | University | United States | 1 | 1 | 0 | 0 | 0 | 0.1 |
| University of Göttingen | University | Germany | 1 | 1 | 0 | 0 | 0 | 0.1 |
| University of Ibadan (UI) | University | Nigeria | 1 | 0 | 1 | 0 | 0 | 0.1 |
| University of Sussex | University | United Kingdom | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Royal Brompton and Harefield NHS Foundation Trust | Other health services | United Kingdom | 3 | 0 | 1 | 0 | 2 | 0.1 |
| Janssen Pharmaceutica | Company | United States | 2 | 0 | 1 | 0 | 1 | 0.1 |
| NimbleGen Systems GmbH | Company | Germany | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Roche Holding AG | Company | United States | 1 | 0 | 1 | 0 | 0 | 0.1 |
| SSI | Other Public | Denmark | 1 | 0 | 1 | 0 | 0 | 0.1 |
| University of Texas Southwestern Medical Center at Dallas | University | United States | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Semmelweis University | University | Hungary | 3 | 0 | 1 | 0 | 2 | 0.1 |
| Ariadne Diagnostics LLC | Company | United States | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Baby Jesus Paediatric Hospital | Other health services | Italy | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Children’s National Health System | Other health services | United States | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Elsevier | Company | Netherlands | 1 | 0 | 1 | 0 | 0 | 0.1 |
| University of Ferrara | University | Italy | 1 | 0 | 1 | 0 | 0 | 0.1 |
| University of Naples Federico II | University | Italy | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Addis Ababa University (AAU) | University | Ethiopia | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Amsterdam Med Univ | NA | Netherlands | 1 | 0 | 1 | 0 | 0 | 0.1 |
| BGI Group | Company | China | 1 | 0 | 1 | 0 | 0 | 0.1 |
| China Academy of Chinese Medical Sciences (CACMS) | Institute | China | 1 | 0 | 1 | 0 | 0 | 0.1 |
| CIBER of Rare Diseases (CIBERER) | Institute | Spain | 1 | 0 | 1 | 0 | 0 | 0.1 |
| CIEN | Other | Spain | 1 | 0 | 1 | 0 | 0 | 0.1 |
| deCODE | Company | Iceland | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Diagnosticum Zrt. | Company | Hungary | 1 | 0 | 1 | 0 | 0 | 0.1 |
| European Inst Syst Biol & Med | NA | France | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Eötvös Loránd University | University | Hungary | 1 | 0 | 1 | 0 | 0 | 0.1 |
| GE Healthcare | Company | Sweden | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Health Research Institute of Santiago (IDIS) | Institute | Spain | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Hôpital universitaire Pitié-Salpêtrière | University Hospital | France | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Knowles Consulting | NA | United Kingdom | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Momenta Pharmaceuticals, Inc. | Company | United States | 1 | 0 | 1 | 0 | 0 | 0.1 |
| PEXA AB | Company | Sweden | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Polyclin Hosp Bros St John God | Other health services | Hungary | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine | Other health services | China | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Tel Aviv Sourasky Medical Center (Ichilov Hospital) | Other health services | Israel | 1 | 0 | 1 | 0 | 0 | 0.1 |
| University Hospital Virgen Arrixaca | University Hospital | Spain | 1 | 0 | 1 | 0 | 0 | 0.1 |
| University of Málaga (UMA) | University | Spain | 1 | 0 | 1 | 0 | 0 | 0.1 |
| University of Murcia | University | Spain | 1 | 0 | 1 | 0 | 0 | 0.1 |
| University of North Carolina at Chapel Hill | University | United States | 1 | 0 | 1 | 0 | 0 | 0.1 |
| University of Santiago de Compostela | University | Spain | 1 | 0 | 1 | 0 | 0 | 0.1 |
| University of Tübingen | University | Germany | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Welcome Trust Ctr Human Genet | NA | United Kingdom | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Amgen Inc | NA | Iceland | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Heinrich Heine Univ Düsseldorf | University | Germany | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Oncomark Ltd | Company | Ireland | 1 | 0 | 1 | 0 | 0 | 0.1 |
| German Center for Diabetes Research (DZD) | Institute | Germany | 3 | 0 | 1 | 2 | 0 | 0.1 |
| VU University Medical Center Amsterdam (VUmc) | University Hospital | Netherlands | 3 | 0 | 1 | 2 | 0 | 0.1 |
| Utrecht University | University | Netherlands | 3 | 0 | 1 | 2 | 0 | 0.1 |
| Perspectum | Company | United Kingdom | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Novo Nordisk | Company | Denmark | 3 | 0 | 1 | 2 | 0 | 0.1 |
| Genentech Inc | NA | United States | 4 | 0 | 1 | 1 | 2 | 0.1 |
| CIBER BBN Inst Salud Carlos III | NA | Spain | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Complejo Hosp Univ A Coruna | NA | Spain | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Ctr Invest Biomed Red CIBER | NA | Spain | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Univ Coruna UDC | University | Spain | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Albanova University Centre | University Other | Sweden | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Cellutech | Company | Sweden | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Abo Akademi University | University | Finland | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Florida Atlantic University | University | United States | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Goethe University Frankfurt | University | Germany | 1 | 0 | 1 | 0 | 0 | 0.1 |
| University of Turku | University | Finland | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Royal Devon & Exeter NHS Fdn Trust | Institute | United Kingdom | 2 | 0 | 1 | 1 | 0 | 0.1 |
| Amsterdam Univ Med Ctr | NA | Netherlands | 2 | 0 | 2 | 0 | 0 | 0.1 |
| Dortmund University of Technology | University | Germany | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Holy Innocents Childrens Hosp | NA | Uganda | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Mbarara University of Science and Technology | University | Uganda | 1 | 0 | 1 | 0 | 0 | 0.1 |
| MSF Epictr Mbarara Res Ctr | Institute | Uganda | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Nanyang Technological University | University | Singapore | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Helsinki University Central Hospital | University Hospital | Finland | 2 | 0 | 0 | 2 | 0 | 0.0 |
| Oxford Univ Hosp NHS Fdn Trust | Institute | United Kingdom | 2 | 0 | 0 | 2 | 0 | 0.0 |
| Danderyds sjukhus | Other health services | Sweden | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Eli Lilly Reg Operat | NA | Austria | 1 | 0 | 0 | 1 | 0 | 0.0 |
| Halmstad University College | University College | Sweden | 1 | 0 | 0 | 1 | 0 | 0.0 |
| Sanofi Aventis Deutschland | NA | Germany | 1 | 0 | 0 | 1 | 0 | 0.0 |
| Steno Diabetes Center | Other health services | Denmark | 1 | 0 | 0 | 1 | 0 | 0.0 |
| Univ Westminister | University | United Kingdom | 1 | 0 | 1 | 0 | 0 | 0.0 |
| German Res Ctr Environem Hlth GmbH | Institute | Germany | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Hlth Data Res UK | NA | United Kingdom | 1 | 0 | 1 | 0 | 0 | 0.0 |
| University of Bath | University | United Kingdom | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Univ Geneva Med Sch | University | Switzerland | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Uppsala Clinical Research Center (UCR) | Institute | Sweden | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Uppsala University Hospital | University Hospital | Sweden | 1 | 0 | 1 | 0 | 0 | 0.0 |
| Novo Nordisk | Company | United Kingdom | 1 | 0 | 0 | 1 | 0 | 0.0 |
| Acclarogen | Company | United Kingdom | 2 | 0 | 0 | 0 | 2 | 0.0 |
| Almirall | Company | Spain | 2 | 0 | 0 | 0 | 2 | 0.0 |
| Amgen Inc | NA | United States | 2 | 0 | 0 | 0 | 2 | 0.0 |
| ARACHOS PHARMA LIMITED | Company | United Kingdom | 2 | 0 | 0 | 0 | 2 | 0.0 |
| Areteva Limited | Company | United Kingdom | 2 | 0 | 0 | 0 | 2 | 0.0 |
| Asthma UK | Other | United Kingdom | 2 | 0 | 0 | 0 | 2 | 0.0 |
| BioSci Consulting | Company | Belgium | 2 | 0 | 0 | 0 | 2 | 0.0 |
| Boehringer Ingelheim | Company | Germany | 2 | 0 | 0 | 0 | 2 | 0.0 |
| Boehringer Ingelheim | Company | Switzerland | 2 | 0 | 0 | 0 | 2 | 0.0 |
| Chiesi Farmaceutici SpA | Company | Italy | 2 | 0 | 0 | 0 | 2 | 0.0 |
| Countess of Chester Hospital NHS Foundation Trust | Other health services | United Kingdom | 2 | 0 | 0 | 0 | 2 | 0.0 |
| CROMSOURCE | Company | Italy | 2 | 0 | 0 | 0 | 2 | 0.0 |
| CROMSOURCE | Company | Spain | 2 | 0 | 0 | 0 | 2 | 0.0 |
| CROMSOURCE | Company | United Kingdom | 2 | 0 | 0 | 0 | 2 | 0.0 |
| European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) | Other health services | Belgium | 2 | 0 | 0 | 0 | 2 | 0.0 |
| European Lung Foundation | Company | United Kingdom | 2 | 0 | 0 | 0 | 2 | 0.0 |
| Fraunhofer-Gesellschaft | Institute | Germany | 2 | 0 | 0 | 0 | 2 | 0.0 |
| Fraunhofer ITEM | Institute | Germany | 2 | 0 | 0 | 0 | 2 | 0.0 |
| Ghent University | University | Belgium | 2 | 0 | 0 | 0 | 2 | 0.0 |
| GlaxoSmithKline | Company | United Kingdom | 2 | 0 | 0 | 0 | 2 | 0.0 |
| International Primary Care Respiratory Group (IPCRG) | Company | United Kingdom | 2 | 0 | 0 | 0 | 2 | 0.0 |
| Jagiellonian University in Krakow | University | Poland | 2 | 0 | 0 | 0 | 2 | 0.0 |
| Janssen Pharmaceutica | Company | United Kingdom | 2 | 0 | 0 | 0 | 2 | 0.0 |
| Lancashire Teaching Hospitals NHS Foundation Trust | Other health services | United Kingdom | 2 | 0 | 0 | 0 | 2 | 0.0 |
| LIAF Italian Anti-Smoking League | Other | Italy | 2 | 0 | 0 | 0 | 2 | 0.0 |
| Longfonds | Other health services | Netherlands | 2 | 0 | 0 | 0 | 2 | 0.0 |
| Manchester University NHS Foundation Trust | Other health services | United Kingdom | 2 | 0 | 0 | 0 | 2 | 0.0 |
| Merck & Co. (MSD) | Company | Belgium | 2 | 0 | 0 | 0 | 2 | 0.0 |
| Merck & Co. (MSD) | Company | United States | 2 | 0 | 0 | 0 | 2 | 0.0 |
| NIHR Southampton Biomedical Research Centre (BRC) | Other health services | United Kingdom | 2 | 0 | 0 | 0 | 2 | 0.0 |
| Pennine Acute Hospitals NHS Trust | Other health services | United Kingdom | 2 | 0 | 0 | 0 | 2 | 0.0 |
| Philips Electronics NV | Company | Netherlands | 2 | 0 | 0 | 0 | 2 | 0.0 |
| Roche Holding AG | Company | Germany | 2 | 0 | 0 | 0 | 2 | 0.0 |
| Synairgen plc | Company | United Kingdom | 2 | 0 | 0 | 0 | 2 | 0.0 |
| Università Cattolica del Sacro Cuore | University | Italy | 2 | 0 | 0 | 0 | 2 | 0.0 |
| University Hospital of Bern (Inselspital) | University Hospital | Switzerland | 2 | 0 | 0 | 0 | 2 | 0.0 |
| University Hospital Southampton NHS Foundation Trust | University Hospital | United Kingdom | 2 | 0 | 0 | 0 | 2 | 0.0 |
| University of Catania | University | Italy | 2 | 0 | 0 | 0 | 2 | 0.0 |
| University of Lyon | University | France | 2 | 0 | 0 | 0 | 2 | 0.0 |
| University of Manchester | University | United Kingdom | 2 | 0 | 0 | 0 | 2 | 0.0 |
| University of Nottingham | University | United Kingdom | 2 | 0 | 0 | 0 | 2 | 0.0 |
| University of Rome Tor Vergata | University | Italy | 2 | 0 | 0 | 0 | 2 | 0.0 |
| European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) | Other health services | Lithuania | 1 | 0 | 0 | 0 | 1 | 0.0 |
| Janssen Pharmaceutica | Company | Belgium | 1 | 0 | 0 | 0 | 1 | 0.0 |
| NAFVSM | Company | Netherlands | 1 | 0 | 0 | 0 | 1 | 0.0 |
| St Mary’s Hospital | University Hospital | United Kingdom | 1 | 0 | 0 | 0 | 1 | 0.0 |
| Louisville/Jefferson County Metropolitan Sewer District (MSD) Louisville, Kentucky | Other Public | United States | 1 | 0 | 0 | 0 | 1 | 0.0 |
| Allergy Therapeutics | Company | United Kingdom | 1 | 0 | 0 | 0 | 1 | 0.0 |
| Claude Bernard University Lyon 1 | University | France | 1 | 0 | 0 | 0 | 1 | 0.0 |
| Danish Pediatric Asthma Centre (DPAC) | Other health services | Denmark | 1 | 0 | 0 | 0 | 1 | 0.0 |
| Novartis International AG | Company | Switzerland | 1 | 0 | 0 | 0 | 1 | 0.0 |
| University Hospital of South Manchester | Other health services | United Kingdom | 1 | 0 | 0 | 0 | 1 | 0.0 |
| Publication Year | Publications | Open Access publications | OA gold | OA hybrid | OA green | OA bronze | Not OA | Share OA |
|---|---|---|---|---|---|---|---|---|
| 2014 | 14 | 10 | 5 | 4 | 1 | 0 | 4 | 71.4% |
| 2015 | 7 | 3 | 3 | 0 | 0 | 0 | 4 | 42.9% |
| 2016 | 19 | 14 | 4 | 6 | 1 | 3 | 5 | 73.7% |
| 2017 | 21 | 10 | 5 | 4 | 1 | 0 | 11 | 47.6% |
| 2018 | 15 | 11 | 8 | 2 | 1 | 0 | 4 | 73.3% |
| 2019 | 27 | 24 | 8 | 8 | 5 | 3 | 3 | 88.9% |
| 2020 | 22 | 22 | 16 | 3 | 3 | 0 | 0 | 100.0% |
| Total | 125 | 94 | 49 | 27 | 12 | 6 | 31 | 75.2% |
The Open Access type of the publications was fetched from the Unpaywall REST API. The method to determine the OA type is presented here.
In summary, the different OA types can be described as follows:
Gold: The full text has been found on a publisher website, in a journal that is fully OA.
Hybrid: The full text has been found on a publisher website, in a journal that is not fully OA.
Green: The full text has been found in an institutional repository, such as DiVA.
Bronze: The full text has been found on a publisher website but no OA license could be identified.
N.B.: This table is based on peer-reviewed publications for which Unpaywall could determine the OA type (necessary condition: have a DOI number). Unpaywall’s method is empirical and does not strictly equate to copyright license. As a consequence, the OA status of a given publication may vary with time — for example turning from “Not OA” to “Green” when a full text is added to DiVA.
| Publication Year | Publications | Total Citations | Average Citations | Uncited publications | Share uncited |
|---|---|---|---|---|---|
| 2014 | 2.3 | 112.2 | 47.9 | 0.0 | 0.0% |
| 2015 | 1.2 | 287.7 | 249.5 | 0.0 | 0.0% |
| 2016 | 5.9 | 84.6 | 14.3 | 0.0 | 0.0% |
| 2017 | 2.8 | 150.3 | 54.2 | 0.0 | 0.0% |
| 2018 | 2.4 | 29.4 | 12.2 | 0.0 | 0.0% |
| 2019 | 3.7 | 29.1 | 7.9 | 0.3 | 9.1% |
| 2020 | 2.5 | 10.6 | 4.3 | 0.4 | 16.7% |
| Total | 20.8 | 703.9 | 33.9 | 0.8 | 3.6% |
| Publication years | Publications | Average FWCI | Top 10% publications | Share Top 10% |
|---|---|---|---|---|
| 2014-2016 | 9.4 | 2.18 | 0.6 | 6.3% |
| 2015-2017 | 9.8 | 2.36 | 0.6 | 5.7% |
| 2016-2018 | 11.1 | 1.38 | 0.5 | 4.6% |
| 2017-2019 | 8.5 | 1.62 | 0.3 | 3.0% |
| Total | 17.9 | 1.91 | 0.8 | 4.7% |
This table is based on Scopus publication types Article, Review and Conference Paper.
Rows are based on at least 40 (full counted) publications with good Web of Science coverage (at least 93%).
(DiVA publication type Article, peer review)
Indicators based on < 50 publications are considered unreliable
| Publication years | Publications | Average SNIP | Publications in Top 20% journals | Share Top 20% journals |
|---|---|---|---|---|
| 2014-2016 | 9.1 | 1.17 | 2.4 | 25.7% |
| 2015-2017 | 9.8 | 1.25 | 2.9 | 29.3% |
| 2016-2018 | 11.1 | 1.13 | 3.2 | 28.6% |
| 2017-2019 | 8.9 | 1.35 | 3.2 | 36.0% |
| 2018-2020 | 8.6 | 1.54 | 3.9 | 45.0% |
| Total | 20.5 | 1.36 | 7.3 | 35.7% |
| Publication years | Publications | Corporate co-publications | Share corporate | International co-publications | Share international |
|---|---|---|---|---|---|
| 2014-2016 | 39 | 7 | 17.9% | 21 | 53.8% |
| 2015-2017 | 43 | 5 | 11.6% | 24 | 55.8% |
| 2016-2018 | 49 | 4 | 8.2% | 29 | 59.2% |
| 2017-2019 | 55 | 10 | 18.2% | 39 | 70.9% |
| 2018-2020 | 60 | 19 | 31.7% | 46 | 76.7% |
| Total | 116 | 27 | 23.3% | 78 | 67.2% |
This table is based on Scopus publication types Article, Review and Conference Paper.
Rows are based on at least 39 (full counted) publications with good Web of Science coverage (at least 93.5%).
(DiVA publication type Article, peer review)
Indicators based on < 50 publications are considered unreliable
